title: Thoratec left ventricular assist device removal after toxic myocarditis.
abstract: The clinical manifestation and natural history of myocarditis range is variable from asymptomatic stages to intractable circulatory compromise and death. Supportive therapy is paramount in the treatment of this condition. The use of mechanical circulatory support as bridge-to-recovery or bridge-to-transplantation in cases of cardiovascular collapse is often the only therapeutic option for these patients. We report the case of an adolescent boy with toxic myocarditis, due to cannabis abuse, who was supported with a Thoratec left ventricular assist device (Thoratec Laboratories Corp, Pleasanton, CA) for 96 days before device removal.
authors.affiliation: Department of Thoracic and Cardiovascular Medicine, Heart and Diabetes Center North-Rhine Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, Germany.
authors.forename: Evangelos
authors.initials: E
authors.lastname: Leontiadis
authors.forename: Michiel
authors.initials: M
authors.lastname: Morshuis
authors.forename: Latif
authors.initials: L
authors.lastname: Arusoglu
authors.forename: Dagmar
authors.initials: D
authors.lastname: Cobaugh
authors.forename: Reiner
authors.initials: R
authors.lastname: Koerfer
authors.forename: Aly
authors.initials: A
authors.lastname: El-Banayosy
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D002188:Cannabis / Q000506:poisoning*; D002315:Cardiopulmonary Bypass; D020878:Device Removal / Q000379:methods*; D004867:Equipment Design; D004869:Equipment Safety; D005500:Follow-Up Studies; D006333:Heart Failure / Q000139:chemically induced / Q000601:surgery; D006353:Heart-Assist Devices; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000139:chemically induced* / Q000601:surgery*; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016896:Treatment Outcome